Submitted:
27 May 2026
Posted:
29 May 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Case Presentation

3. Discussion
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Informed Consent
Data Availability
Acknowledgments
Conflicts of Interest
References
- Sharma, N.C.; Efstratiou, A.; Mokrousov, I.; Mutreja, A.; Das, B.; Ramamurthy, T. Diphtheria. Nat. Rev. Dis. Prim. 2019, 5, 81. [Google Scholar] [CrossRef] [PubMed]
- Parveen, S.; Bishai, W.R.; Murphy, J.R. Corynebacterium diphtheriae: Diphtheria Toxin, the tox Operon, and Its Regulation by Fe2+ Activation of apo-DtxR. Microbiol. Spectr. 2019, 7. [Google Scholar] [CrossRef] [PubMed]
- Hadfield, T.L.; McEvoy, P.; Polotsky, Y.; Tzinserling, V.A.; Yakovlev, A.A. The pathology of diphtheria. J. Infect. Dis. 2000, 181, S116–S120. [Google Scholar] [CrossRef] [PubMed]
- Byard, R.W. Diphtheria—‘The strangling angel’ of children. J. Forensic Leg. Med. 2013, 20, 65–68. [Google Scholar] [CrossRef] [PubMed]
- Lovelock, T.; du Plessis, M.; van der Westhuizen, C.; et al. Non-toxigenic Corynebacterium diphtheriae endocarditis: A cluster of five cases. S. Afr. J. Infect. Dis. 2024, 39, 539. [Google Scholar] [CrossRef] [PubMed]
- Sharma, N.C.; Efstratiou, A.; Mokrousov, I.; Mutreja, A.; Das, B.; Ramamurthy, T. Diphtheria. Nat. Rev. Dis. Prim. 2019, 5, 81. [Google Scholar] [CrossRef] [PubMed]
- Truelove, S.A.; Keegan, L.T.; Moss, W.J.; et al. Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled Analysis. Clin. Infect. Dis. 2020, 71, 89–97. [Google Scholar] [CrossRef] [PubMed]
- Clarke, K.E.N.; MacNeil, A.; Hadler, S.; Scott, C.; Tiwari, T.S.P.; Cherian, T. Global Epidemiology of Diphtheria, 2000-20171. Emerg. Infect. Dis. 2019, 25, 1834–1842. [Google Scholar] [CrossRef] [PubMed]
- Yu, H.; Nagafuchi, Y.; Fujio, K. Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus. Biomolecules 2021, 11, 928. [Google Scholar] [CrossRef] [PubMed]
- Wang, A.; Gaca, J.G.; Chu, V.H. Management Considerations in Infective Endocarditis: A Review. JAMA 2018, 320, 72–83. [Google Scholar] [CrossRef] [PubMed]
- Khaledi, M.; Sameni, F.; Afkhami, H.; Hemmati, J.; Asareh Zadegan Dezfuli, A.; Sanae, M.J.; Validi, M. Infective endocarditis by HACEK: A review. J. Cardiothorac. Surg. 2022, 17, 185. [Google Scholar] [CrossRef] [PubMed]
- Ott, L.; Möller, J.; Burkovski, A. Interactions between the Re-Emerging Pathogen Corynebacterium diphtheriae and Host Cells. Int. J. Mol. Sci. 2022, 23, 3298. [Google Scholar] [CrossRef] [PubMed]
- Sangal, V.; Blom, J.; Sutcliffe, I.C.; von Hunolstein, C.; Burkovski, A.; Hoskisson, P.A. Adherence and invasive properties of Corynebacterium diphtheriae strains correlates with the predicted membrane-associated and secreted proteome. BMC Genom. 2015, 16, 765. [Google Scholar] [CrossRef] [PubMed]
- Wada, H.; Matsumoto, T.; Yamashita, Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J. Intensive Care 2014, 2, 15. [Google Scholar] [CrossRef] [PubMed]


| Test: hemoculture; Pathogen: C. diphtheriae; Concentration: 10^5 CFU/mL | ||
| Antibiotic | MIC | Efficacy profile |
| Amoxicillin | 0.125 | S |
| Cefotaxime | 0.5 | I |
| Ciprofloxacin | 0.75 | R |
| Clindamycin | 0.38 | S |
| Doxycycline | 0.125 | S |
| Erythromycin | 0.047 | S |
| Linezolid | 0.19 | S |
| Meropenem | 0.064 | S |
| G penicillin | 0.094 | I |
| Rifampicin | < 0.002 | S |
| Tetracycline | 0.19 | S |
| Trimethoprim/sulfamethoxazole | 1.5 | R |
| JAAM Score | Our Case Report | ||
| Factors | Points | Parameters | Points |
| Platelet count | |||
| <80 × 10^3 u/μL or >50% decrease within 24 h |
3 | 50 × 10^3 u/μL | 3 |
| ≥80 × 10^3 and <120 × 10^3 u/μL or 30–50% decrease between 24 h |
1 | ||
| ≥120.000 | 0 | ||
| INR | |||
| ≥1.2 | 1 | 1.32 | 1 |
| <1.2 | 0 | ||
SIRS score:
| |||
| ≥3 positive parameters | 1 | 3 parameters | 1 |
| <3 positive parameters | 0 | ||
| Fibrine degradation products | |||
| D-dimer ≥ 25 μg/mL | 3 | 2.75 | 0 |
| D-Dimer 10–25 μg/mL | 1 | ||
| D-dimer < 10 μg/mL | 0 | ||
| Total (≥4 is diagnostic for DIC) | 5 | ||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).